Clinical trials
Bronchiectasis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 11 |
| Terminated | 7 |
| Unknown status | 4 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 5 |
| University of Edinburgh | 5 |
| Papworth Hospital NHS Foundation Trust | 4 |
| Bayer | 3 |
| Boehringer Ingelheim | 3 |
| University of Ulster | 3 |
| AstraZeneca | 2 |
| Belfast Health and Social Care Trust | 2 |
| GlaxoSmithKline | 2 |
| Insmed Incorporated | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiectasis | 58 |
| Pulmonary Disease, Chronic Obstructive | 11 |
| Asthma | 10 |
| Cystic Fibrosis | 5 |
| Lung Diseases, Interstitial | 5 |
| Lung Diseases | 3 |
| Pseudomonas Infections | 3 |
| Respiratory Tract Diseases | 3 |
| Dyspnea | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 26 to 50 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.